SCHEMBL13749573

SCHEMBL13749573

CCc1ccc(-c2ccccc2Cl)o1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ ALDH1A1 P00352 5/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ S1PR4 O95977 1/20 0.45
▸ ERCC5 P28715 1/20 0.44
▸ FEN1 P39748 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ RAB9A P51151 4/20 0.43
▸ HPGD P15428 2/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ SLC9A1 P19634 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12903065 0.82 FTO (0.54) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL282040 0.81 ALDH1A1 (0.53) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL12715362 0.81 CYP3A4 (0.56) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL13718652 0.81 MAPT (0.48) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL805123 0.79 HSD17B2 (0.52) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL805163 0.79 ALDH1A1 (0.46) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL6395900 0.78 ALDH1A1 (0.46) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL27669358 0.76 ALDH1A1 (0.59) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL1616485 0.75 ALDH1A1 (0.53) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL16316327 0.74 SMN1; SMN2 (0.48) LMNAMAPTALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579479-B2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-25 — — US disclosed
US-7241780-B2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method BRISTOLS-MYERS SQUIBB COMPANY (US) 2007-07-10 — — US disclosed
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method CHENG PETER T 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method GPR119, LIPC, ACACA LMNA 320/4885MAPT 4848/4885ALDH1A1 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback